Al-Monajjed R - Search Results

1

Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS Study.

Valentin B, Arsov C, Ullrich T, Al-Monajjed R, Boschheidgen M, Hadaschik BA, Giganti F, Giessing M, Lopez-Cotarelo C, Esposito I, Antoch G, Albers P, Radtke JP, Schimmöller L. Valentin B, et al. Among authors: al monajjed r. Eur Urol Open Sci. 2023 Dec 19;59:30-38. doi: 10.1016/j.euros.2023.10.005. eCollection 2024 Jan. Eur Urol Open Sci. 2023. PMID: 38298772 Free PMC article.

2

[Effect of performing a single PSA screening : The CAP trial].

Al-Monajjed R, Arsov C, Albers P. Al-Monajjed R, et al. Urologe A. 2018 Sep;57(9):1137-1138. doi: 10.1007/s00120-018-0678-3. Urologe A. 2018. PMID: 29796696 German. No abstract available.

3

[Prostate cancer screening: controversies and suggested solutions].

Al-Monajjed R, Arsov C, Albers P. Al-Monajjed R, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Dec;61(12):1544-1550. doi: 10.1007/s00103-018-2840-x. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018. PMID: 30397721 Review. German.

4

Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy.

Klingebiel M, Arsov C, Ullrich T, Quentin M, Al-Monajjed R, Mally D, Sawicki LM, Hiester A, Esposito I, Albers P, Antoch G, Schimmöller L. Klingebiel M, et al. Eur J Radiol. 2021 Apr;137:109587. doi: 10.1016/j.ejrad.2021.109587. Epub 2021 Feb 10. Eur J Radiol. 2021. PMID: 33592552

5

[Risk-adapted prostate cancer screening-update 2021].

Al-Monajjed R, Arsov C, Albers P. Al-Monajjed R, et al. Urologe A. 2021 May;60(5):592-601. doi: 10.1007/s00120-021-01505-9. Epub 2021 Apr 1. Urologe A. 2021. PMID: 33792743 Review. German.

6

[The PRECISE study: change or standstill in PCa diagnostics?].

Al-Monajjed R, Schimmöller L. Al-Monajjed R, et al. Urologe A. 2021 Oct;60(10):1336-1338. doi: 10.1007/s00120-021-01592-8. Epub 2021 Jul 8. Urologe A. 2021. PMID: 34236457 German. No abstract available.

7

Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer.

Valentin B, Arsov C, Ullrich T, Demetrescu D, Morawitz J, Al-Monajjed R, Quentin M, Kirchner J, Esposito I, Albers P, Antoch G, Schimmöller L. Valentin B, et al. Eur J Radiol. 2022 Feb;147:110110. doi: 10.1016/j.ejrad.2021.110110. Epub 2021 Dec 17. Eur J Radiol. 2022. PMID: 34952329

8

[The IMPACT study-PSA-based prostate screening in Lynch syndrome].

Al-Monajjed R, Serón-Möller RF, Radtke JP. Al-Monajjed R, et al. Urologe A. 2022 May;61(5):534-536. doi: 10.1007/s00120-022-01809-4. Epub 2022 Apr 11. Urologe A. 2022. PMID: 35403897 German. No abstract available.

9

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate.

Boschheidgen M, Schimmöller L, Doerfler S, Al-Monajjed R, Morawitz J, Ziayee F, Mally D, Quentin M, Arsov C, Albers P, Antoch G, Ullrich T. Boschheidgen M, et al. Sci Rep. 2022 Apr 25;12(1):6746. doi: 10.1038/s41598-022-10859-9. Sci Rep. 2022. PMID: 35469056 Free PMC article.

10

Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins.

Quentin M, Schimmöller L, Ullrich T, Valentin B, Demetrescu D, Al-Monajjed R, Mally D, Esposito I, Albers P, Antoch G, Arsov C. Quentin M, et al. Abdom Radiol (NY). 2022 Jul;47(7):2486-2493. doi: 10.1007/s00261-022-03543-z. Epub 2022 May 16. Abdom Radiol (NY). 2022. PMID: 35578110 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters